{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:10:48Z","timestamp":1792624248102,"version":"4.5.0"},"reference-count":73,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,8,25]]},"DOI":"10.18632\/aging.103910","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T15:05:33Z","timestamp":1598367933000},"page":"16621-16646","source":"Crossref","is-referenced-by-count":16,"title":["Prolonged treatment with Y-27632 promotes the senescence of primary human dermal fibroblasts by increasing the expression of IGFBP-5 and transforming them into a CAF-like phenotype"],"prefix":"10.18632","volume":"12","author":[{"given":"Xiangyong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"},{"name":"Key Laboratory of Biotechnology and Biological Resource Utilization in Universities of Shandong and College of Life Science, Dezhou University, Dezhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"},{"name":"Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Outpatient Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Biotechnology and Biological Resource Utilization in Universities of Shandong and College of Life Science, Dezhou University, Dezhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"},{"name":"Department of Stomatology, Shengli Oilfield Central Hospital, Dongying, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Tissue Engineering and Regeneration, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"29051","DOI":"10.1074\/jbc.270.49.29051","article-title":"A novel serine\/threonine kinase binding the ras-related RhoA GTPase which translocates the kinase to peripheral membranes.","volume":"27","author":"Lim","year":"1995","journal-title":"J Biol Chem"},{"key":"2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev.cellbio.17.1.351","article-title":"Animal cell cytokinesis.","volume":"1","author":"Glotzer","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks.","volume":"1","author":"D\u2019Souza-Schorey","year":"1997","journal-title":"Genes Dev"},{"key":"4","doi-asserted-by":"publisher","first-page":"1171301","DOI":"10.1242\/jcs.01118","article-title":"Rho-family GTPases: it's not only Rac and Rho (and I like it).","author":"Der","year":"2004","journal-title":"J Cell Sci"},{"key":"5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1124\/jpet.106.110635","article-title":"Novel rho kinase inhibitors with anti-inflammatory and vasodilatory activities.","volume":"32","author":"Webb","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1620\/tjem.211.309","article-title":"Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.","volume":"21","author":"Shimokawa","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1358\/dnp.2004.17.8.863696","article-title":"Rho-kinase, a potential therapeutic target for the treatment of hypertension.","volume":"1","author":"Takeshita","year":"2004","journal-title":"Drug News Perspect"},{"key":"8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine.","volume":"2","author":"Takeshita","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","article-title":"Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.","volume":"23","author":"Ohtomo","year":"2005","journal-title":"J Neurol Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1349-7006.2000.tb01018.x","article-title":"Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.","volume":"9","author":"Akedo","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neuro.2009.12.010","article-title":"Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.","volume":"3","author":"Lu","year":"2010","journal-title":"Neurotoxicology"},{"key":"12","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","article-title":"Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.","volume":"6","author":"Rosenblatt","year":"2009","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrurol.2014.278","article-title":"Understanding and targeting the rho kinase pathway in erectile dysfunction.","volume":"1","author":"Bivalacqua","year":"2014","journal-title":"Nat Rev Urol"},{"key":"14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/OPTH.S41000","article-title":"An emerging treatment option for glaucoma: rho kinase inhibitors.","volume":"8","author":"Chang","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s12017-015-8374-6","article-title":"Role of rho kinase and fasudil on synaptic plasticity in multiple sclerosis.","volume":"1","author":"Xiao","year":"2015","journal-title":"Neuromolecular Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1124\/jpet.111.191239","article-title":"Effect of fasudil, a selective inhibitor of rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.","volume":"34","author":"Cuzzocrea","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.neuint.2012.08.003","article-title":"ROCK inhibition with Y27632 promotes the proliferation and cell cycle progression of cultured astrocyte from spinal cord.","volume":"6","author":"Luo","year":"2012","journal-title":"Neurochem Int"},{"key":"18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pupt.2017.08.002","article-title":"Effects of fasudil on pulmonary hypertension in clinical practice.","volume":"4","author":"Wu","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a rho-associated protein kinase in hypertension.","volume":"38","author":"Narumiya","year":"1997","journal-title":"Nature"},{"key":"20","first-page":"976","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.","volume":"5","author":"Narumiya","year":"2000","journal-title":"Mol Pharmacol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/sj.leu.2404762","article-title":"The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34CML progenitor cells.","volume":"2","author":"Whetton","year":"2007","journal-title":"Leukemia"},{"key":"22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1139\/y09-043","article-title":"Rho-kinase inhibitors Y-27632 and fasudil prevent agonist-induced vasospasm in human radial artery.","volume":"8","author":"Parlak","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/ced.12067","article-title":"Effects of Y27632 on keratinocyte procurement and wound healing.","volume":"3","author":"Zhang","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0168-8278(01)00169-6","article-title":"Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells.","volume":"3","author":"Imamura","year":"2001","journal-title":"J Hepatol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.freeradbiomed.2011.03.020","article-title":"Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis.","volume":"5","author":"Su","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cbf.3382","article-title":"An in vitro study of scarring formation mediated by human tenon fibroblasts: effect of Y-27632, a rho kinase inhibitor.","volume":"3","author":"Kiuchi","year":"2019","journal-title":"Cell Biochem Funct"},{"key":"27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnins.2014.00304","article-title":"The rho kinase inhibitor Y-27632 improves motor performance in male SOD1mice.","volume":"8","author":"T\u00f6nges","year":"2014","journal-title":"Front Neurosci"},{"key":"28","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/1873-3468.13087","article-title":"Rho signaling research: history, current status and future directions.","volume":"59","author":"Thumkeo","year":"2018","journal-title":"FEBS Lett"},{"key":"29","first-page":"861","article-title":"Pharmacological inhibition of rho-kinase signaling with Y-27632 blocks melanoma tumor growth.","volume":"2","author":"Sullivan","year":"2010","journal-title":"Oncol Rep"},{"key":"30","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1111\/cas.13786","article-title":"ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells.","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Sci"},{"key":"31","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1089\/ten.TEA.2011.0616","article-title":"Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction.","volume":"1","author":"Schalkwijk","year":"2012","journal-title":"Tissue Eng Part A"},{"key":"32","doi-asserted-by":"publisher","first-page":"e1251","DOI":"10.1002\/term.2526","article-title":"Y-27632 simplifies the isolation procedure of human primary epidermal cells by selectively blocking focal adhesion of dermal cells.","volume":"1","author":"Wu","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/pmic.201400417","article-title":"Rho-kinase inhibitor Y-27632 increases cellular proliferation and migration in human foreskin fibroblast cells.","volume":"1","author":"Lammi","year":"2015","journal-title":"Proteomics"},{"key":"34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tcb.2013.08.006","article-title":"Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer.","volume":"2","author":"Dotto","year":"2013","journal-title":"Trends Cell Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2012.03.048","article-title":"Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.","volume":"14","author":"Dotto","year":"2012","journal-title":"Cell"},{"key":"36","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cancers7040902","article-title":"Cancer-associated fibroblasts: their characteristics and their roles in tumor growth.","volume":"7","author":"Takeyama","year":"2015","journal-title":"Cancers (Basel)"},{"key":"37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s13277-015-3230-8","article-title":"Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.","volume":"3","author":"Sun","year":"2015","journal-title":"Tumour Biol"},{"key":"38","doi-asserted-by":"publisher","first-page":"6843","DOI":"10.1158\/0008-5472.CAN-13-1791","article-title":"Tumor-stroma interaction: revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis.","volume":"7","author":"Wrana","year":"2013","journal-title":"Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1186\/bcr138","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.","volume":"5","author":"Cunha","year":"1999","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature08486","article-title":"Pten in stromal fibroblasts suppresses mammary epithelial tumours.","volume":"46","author":"Sharma","year":"2009","journal-title":"Nature"},{"key":"41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression.","volume":"5","author":"Campisi","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"42","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1091\/mbc.E11-10-0884","article-title":"Lamin B1 loss is a senescence-associated biomarker.","volume":"2","author":"Campisi","year":"2012","journal-title":"Mol Biol Cell"},{"key":"43","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00424-009-0659-x","article-title":"RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes.","volume":"45","author":"Simonides","year":"2009","journal-title":"Pflugers Arch"},{"key":"44","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1095\/biolreprod.110.085969","article-title":"GATA depletion impacts insulin-like growth factor 1 mRNA and protein levels in luteinizing porcine granulosa cells.","volume":"8","author":"Hui","year":"2010","journal-title":"Biol Reprod"},{"key":"45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/gutjnl-2013-306596","article-title":"Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.","volume":"6","author":"Yu","year":"2015","journal-title":"Gut"},{"key":"46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41588-017-0034-3","article-title":"Genetic determinants and epigenetic effects of pioneer-factor occupancy.","volume":"5","author":"Cacchiarelli","year":"2018","journal-title":"Nat Genet"},{"key":"47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cm.20168","article-title":"Molecular characterization of the effects of Y-27632.","volume":"6","author":"Mandato","year":"2007","journal-title":"Cell Motil Cytoskeleton"},{"key":"48","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1097\/01.ju.0000085024.47406.6c","article-title":"Y-27632, a rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.","volume":"17","author":"Cellek","year":"2003","journal-title":"J Urol"},{"key":"49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.theriogenology.2015.09.020","article-title":"ROCK inhibitor Y27632 promotes proliferation and diminishes apoptosis of marmoset induced pluripotent stem cells by suppressing expression and activity of caspase 3.","volume":"8","author":"He","year":"2016","journal-title":"Theriogenology"},{"key":"50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.exger.2018.02.012","article-title":"A crucial role of ROCK for alleviation of senescence-associated phenotype.","volume":"10","author":"Park","year":"2018","journal-title":"Exp Gerontol"},{"key":"51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4161\/cc.11.4.19172","article-title":"The STAT3-IGFBP5 axis is critical for IL-6\/gp130-induced premature senescence in human fibroblasts.","volume":"1","author":"Nakajima","year":"2012","journal-title":"Cell Cycle"},{"key":"52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/cdd.2013.161","article-title":"Sprouty1 induces a senescence-associated secretory phenotype by regulating NF\u03baB activity: implications for tumorigenesis.","volume":"2","author":"Encinas","year":"2014","journal-title":"Cell Death Differ"},{"key":"53","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1096\/fj.08-114124","article-title":"IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo.","volume":"2","author":"Pell","year":"2009","journal-title":"FASEB J"},{"key":"54","first-page":"626","article-title":"Effects of insulin-like growth factor binding protein 5 on the proliferation and invasion of osteosarcoma cells.","volume":"2","author":"Zhang","year":"2012","journal-title":"Chinese Journal of Clinical Oncology"},{"key":"55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/path.2280","article-title":"Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.","volume":"21","author":"Lin","year":"2008","journal-title":"J Pathol"},{"key":"56","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1038\/onc.2011.97","article-title":"Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.","volume":"3","author":"Luo","year":"2011","journal-title":"Oncogene"},{"key":"57","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.biocel.2004.10.013","article-title":"The signals and pathways activating cellular senescence.","volume":"3","author":"Weinberg","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cell.2017.07.049","article-title":"SnapShot: Cellular Senescence Pathways.","volume":"17","author":"Bischof","year":"2017","journal-title":"Cell"},{"key":"59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/a:1009618824145","article-title":"Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis.","volume":"4","author":"Weinstein","year":"1999","journal-title":"Apoptosis"},{"key":"60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death\u2014apoptosis, autophagy and senescence.","volume":"27","author":"Chambard","year":"2010","journal-title":"FEBS J"},{"key":"61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","article-title":"Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis.","volume":"1","author":"Hay","year":"2008","journal-title":"Cancer Cell"},{"key":"62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molcel.2011.02.020","article-title":"Activation of the PIK3CA\/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.","volume":"4","author":"Adams","year":"2011","journal-title":"Mol Cell"},{"key":"63","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ncb3228","article-title":"Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.","volume":"1","author":"Neel","year":"2015","journal-title":"Nat Cell Biol"},{"key":"64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/15384101.2015.1130091","article-title":"CSL-p53: from senescence to CAF activation.","volume":"1","author":"Dotto","year":"2016","journal-title":"Cell Cycle"},{"key":"65","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/B978-0-323-03961-1.50088-X","volume-title":"Comprehensive Hypertension","author":"Hall","year":"2007"},{"key":"66","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3892\/or.2017.5515","article-title":"ROCK inhibition as a potential therapeutic target involved in apoptosis in hemangioma.","volume":"3","author":"Ou","year":"2017","journal-title":"Oncol Rep"},{"key":"67","doi-asserted-by":"publisher","first-page":"772","DOI":"10.15252\/msb.20145450","article-title":"ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.","volume":"1","author":"Peeper","year":"2014","journal-title":"Mol Syst Biol"},{"key":"68","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential.","volume":"5","author":"Li","year":"2016","journal-title":"J Med Chem"},{"key":"69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/cells9010245","article-title":"RhoA-ROCK signaling as a therapeutic target in traumatic brain injury.","volume":"9","author":"Tolias","year":"2020","journal-title":"Cells"},{"key":"70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/scrt449","article-title":"The effect of rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional.","volume":"5","author":"McBride","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"71","doi-asserted-by":"publisher","first-page":"e1007366","DOI":"10.1371\/journal.pgen.1007366","article-title":"The ARE-binding protein tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.","volume":"1","author":"Hofbauer","year":"2018","journal-title":"PLoS Genet"},{"key":"72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-9473-1_18","article-title":"Human Reconstructed Skin in a Mouse Model.","volume":"199","author":"Wu","year":"2019","journal-title":"Methods Mol Biol"},{"key":"73","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1089\/ten.TEA.2013.0759","article-title":"Full-thickness skin with mature hair follicles generated from tissue culture expanded human cells.","volume":"2","author":"Stenn","year":"2014","journal-title":"Tissue Eng Part A"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:34:14Z","timestamp":1602236054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":73,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,8,31]]}},"alternative-id":["103910","32843583"],"URL":"https:\/\/doi.org\/10.18632\/aging.103910","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}